RGEN

Repligen Corporation
$176.27
-5.76 (-3.16%)
Mkt Cap 9.95B
Volume 818,689
52W Range 100.99-188.73
Sector Healthcare
Beta 1.01
EPS (TTM) 0.74 USD
P/E Ratio 238.20
Revenue (TTM) 785.10M USD
Rev Growth (5Y) +15.1%
EPS Growth (5Y) -5.3%
AlphaVal · Fair Value
What we estimate one share is worth
$50.27
Overvalued strong signal
250.6% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
C
Platform & Compounding FCF
52.8 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 738.26M 634.44M 632.36M 801.54M 670.53M 366.26M 270.25M 194.03M 141.24M 104.54M 83.54M 63.55M
Net Income 48.89M (25.51M) 35.60M 185.96M 128.29M 59.93M 21.41M 16.62M 28.35M 11.68M 9.35M 8.17M
EPS 0.87 -0.46 0.64 3.35 2.33 1.14 0.44 0.38 0.74 0.35 0.28 0.25
Free Cash Flow 93.90M 142.49M 74.93M 38.74M 51.93M 36.28M 44.06M 18.73M 12.00M 3.20M 12.43M 12.80M
FCF / Share 1.67 2.55 1.34 0.70 0.94 0.69 0.91 0.43 0.31 0.10 0.38 0.39
Operating CF 117.42M 175.39M 113.92M 172.08M 119.02M 62.62M 67.22M 32.77M 17.45M 7.52M 15.05M 18.40M
Total Assets 2.95B 2.83B 2.83B 2.53B 2.36B 1.90B 1.40B 139.45M 120.41M 288.91M 146.24M (65.43M)
Total Debt 689.95M 686.25M 711.80M 422.96M 366.05M 275.42M 263.32M 103.49M 99.25M 95.27M 0 0
Cash & Equiv 566.02M 757.36M 751.32M 523.46M 603.81M 717.29M 528.39M 193.82M 173.76M 141.78M 73.41M 62.00M
Book Value 2.11B 1.97B 1.96B 1.91B 1.75B 1.53B 1.06B 615.57M 591.55M 168.76M 122.75M 111.73M
Return on Equity 0.02 -0.01 0.02 0.10 0.07 0.04 0.02 0.03 0.05 0.07 0.08 0.07
RGEN News
Why Is Repligen (RGEN) Up 27.7% Since Last Earnings Report?
Aug 27, 2026 08:35 AM · zacks.com
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen
Aug 27, 2026 01:31 AM · zacks.com
American Capital Management Inc. Makes New $49.26 Million Investment in Repligen Corporation $RGEN
Aug 27, 2026 12:43 AM · defenseworld.net
5 Biotech Stocks Worth Adding to Your Portfolio Now
Aug 26, 2026 07:20 AM · zacks.com
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
Aug 26, 2026 03:30 AM · globenewswire.com
25,992 Shares in Repligen Corporation $RGEN Acquired by Bank of Nova Scotia
Aug 26, 2026 01:08 AM · defenseworld.net
Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here's Who's Best Positioned.
Aug 25, 2026 03:15 AM · 247wallst.com
B. Metzler seel. Sohn & Co. AG Takes $3.60 Million Position in Repligen Corporation $RGEN
Aug 21, 2026 11:58 PM · defenseworld.net
Repligen Corporation $RGEN Shares Acquired by Avidity Partners Management LP
Jul 31, 2026 11:50 PM · defenseworld.net
Wall Street Analysts Believe Repligen (RGEN) Could Rally 25.72%: Here's is How to Trade
Jul 30, 2026 06:56 AM · zacks.com